| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |